肿瘤相关中性粒细胞密度在接受根治性放疗的宫颈癌中的意义
研究纳入1996年1月至2011年12月接受根治性放疗的FIGO IB-IVA期宫颈癌患者,用免疫组化检测初诊活检标本CD66b表达以评估肿瘤相关中性粒细胞(TAN)密度。250例标本中209例(83.6%)可见CD66b阳性细胞,TAN密度高与无进展生存期(PFS)缩短显著相关,多因素分析显示TAN增多是PFS短的独立预后因素(HR 4.95)。
要点
- 250例宫颈癌标本中209例(83.6%)检出CD66b阳性TAN。
- TAN密度高与PFS缩短显著相关。
- TAN增多是接受根治性放疗宫颈癌患者PFS短的独立预后因素(HR 4.95)。
核心结论
- 肿瘤内TAN密度是接受根治性放疗的宫颈癌患者PFS短的独立预后因素。
研究设计与样本
- 收集1996年1月至2011年12月接受根治性放疗的FIGO IB-IVA期宫颈癌患者的基线特征和结局数据。
- 用初诊时活检标本经免疫组化评估宫颈肿瘤CD66b表达水平。
- 采用单因素和多因素分析评估肿瘤内TAN密度与临床病理特征及PFS的关系。
主要发现
- 250例宫颈癌标本中209例(83.6%)可见CD66b阳性细胞(TAN)。
- TAN密度与PFS缩短显著相关。
- 多因素分析显示TAN增多是PFS短的独立预后因素(HR 4.95;95%CI 2.51-10.7;p<0.0001)。
- FIGO IVB期疾病(HR 2.64;95%CI 1.38-5.01;p=0.01)为PFS短的独立预后因素。
- 非鳞状细胞癌(SCC)组织学(HR 2.50;95%CI 1.23-4.64;p=0.01)、较大肿瘤(HR 1.58;95%CI 1.03-2.40;p=0.04)和盆腔淋巴结转移(HR 2.24;95%CI 1.48-3.38;p=0.0001)为PFS短的独立预后因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to investigate the prognostic significance of tumor-associated neutrophil (TAN) density in cervical cancer patients that were treated with definitive radiotherapy. METHODS: The baseline characteristics and outcome data of FIGO stages IB-IVA cervical cancer patients who were treated with definitive radiotherapy between January 1996 and December 2011 were collected. Using biopsy samples obtained at the time of the initial diagnosis, the expression levels of CD66b in the patients' cervical tumors were evaluated by immunohistochemistry. Univariate and multivariate analyses were performed to evaluate the relationships between intratumoral TAN density and various clinicopathological features as well as progression-free survival (PFS) in these patients. RESULTS: The CD66b-positive cells (TAN) were observed in 209 (83.6%) of 250 cervical cancer specimens. The TAN density was significantly associated with shorter PFS. Multivariate analysis identified an increased number of TAN (hazard ratio [HR]: 4.95; 95% confidence interval [CI]: 2.51-10.7; p<0.0001), FIGO stage IVB disease (HR: 2.64; 95% CI: 1.38-5.01; p=0.01), non-squamous cell carcinoma (SCC) histology (HR: 2.50; 95% CI: 1.23-4.64; p=0.01), larger tumors (HR: 1.58; 95% CI: 1.03-2.40; p=0.04), and pelvic lymph node metastasis (HR: 2.24; 95% CI: 1.48-3.38; p=0.0001) as independent prognostic factors for short PFS. CONCLUSION: Intratumoral TAN density is an independent prognostic factor for short PFS in cervical cancer patients treated with definitive radiotherapy.
引用
- Matsumoto Y, Mabuchi S, Kozasa K, et al. The significance of tumor-associated neutrophil density in uterine cervical cancer treated with definitive radiotherapy. Gynecol Oncol. 2017. PMID: 28552395. doi:10.1016/j.ygyno.2017.02.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。